Compare AU
Compare DRUG vs. ESGI
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the MSCI Global Sustainable (ESGI). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | ESGI | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 63 | 1,227 |
Median incremental investment | $967.00 | $743.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $1,910.97 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | ESGI | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | The fund exists to track the performance of the MSCI World ex-Australia ex-Fossil Fuel Select SRI and Low Carbon Capped Index before considering any fees, expenses, and taxes. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | ASML Holding NV (5.16 %) Novo Nordisk AS Class B (5.00 %) Adobe Inc (4.71 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Information Technology (54.21 %) Health Care (20.75 %) Other (15.14 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (45.82 %) Japan (9.48 %) Netherlands (6.76 %) |
Management fee | 0.57 % | 0.55 % |
Key Summary
DRUG | ESGI | |
|---|---|---|
Issuer | BetaShares | VanEck |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | MSCI World ex Australia ex Fossil Fuel Select SRI and Low Carbon Capped Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.55 % |
Price | $8.25 | $37.42 |
Size | $182.401 million | $202.822 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 3.26 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 08/03/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | ESGI | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 63 | 1,227 |
Median incremental investment | $967.00 | $743.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $1,910.97 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | ESGI | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | ESGI |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |